Who should get the new five-strain meningitis vaccine? Experts weigh in.

A key national vaccine committee has released its official guidance on who should get a newer meningitis vaccine. The recommendations focus on Pfizer's pentavalent vaccine, which protects against five strains of meningococcal bacteria, for people aged 10 years and older in the United States. This type of report doesn't contain new research data on how effective the shot is or what side effects people might experience. Instead, it translates existing evidence into practical advice for doctors and patients. It's important to understand this is a recommendation, not a study reporting results. The guidance gives families and healthcare providers a clearer path forward when considering this vaccine option, based on the committee's review of all available information.